HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shigeru Yoshida Selected Research

Phenetidine

11/2004Effects of SEA0400, a novel inhibitor of the Na+/Ca2+ exchanger, on myocardial stunning in anesthetized dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shigeru Yoshida Research Topics

Disease

8Type 2 Diabetes Mellitus (MODY)
11/2016 - 09/2010
8Stroke (Strokes)
05/2008 - 08/2002
7Hyperalgesia
07/2019 - 11/2007
5Infarction (Infarctions)
03/2017 - 08/2002
5Ischemic Stroke
03/2009 - 08/2002
4Brain Ischemia (Cerebral Ischemia)
03/2017 - 05/2006
3Pain (Aches)
07/2019 - 01/2016
3Visceral Pain
07/2019 - 01/2016
3Neoplasms (Cancer)
01/2018 - 05/2002
3Infections
12/2012 - 01/2008
3Glioma (Gliomas)
05/2009 - 04/2005
3Brain Edema (Cerebral Edema)
03/2009 - 03/2007
2Postpartum Depression (Post-Natal Depression)
07/2022 - 01/2022
2Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
12/2017 - 07/2015
2Overweight
12/2017 - 07/2015
2Prostatic Neoplasms (Prostate Cancer)
01/2017 - 10/2015
2Insulin Resistance
09/2013 - 06/2006
2Carcinogenesis
12/2012 - 10/2002
2Neuroblastoma
05/2009 - 09/2007
2Cognitive Dysfunction
03/2008 - 01/2006
2Alzheimer Disease (Alzheimer's Disease)
03/2008 - 07/2005
2Thrombotic Stroke
10/2007 - 08/2007
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
03/2007 - 08/2002
2Reperfusion Injury
05/2006 - 11/2004
1Liver Diseases (Liver Disease)
12/2022
1Pre-Eclampsia (Preeclampsia)
12/2022
1Pregnancy Complications
12/2022
1Hemolysis
12/2022
1Hemorrhage
11/2021
1Nausea
11/2020
1Vomiting
11/2020
1Headache (Headaches)
11/2020
1Dizziness (Lightheadedness)
11/2020
1Sleepiness
11/2020
1Cytomegalovirus Infections (Inclusion Disease)
06/2019
1Peripheral Nervous System Diseases (PNS Diseases)
01/2019
1Multiple Myeloma
01/2019
1Intractable Pain
01/2018
1Neuralgia (Stump Neuralgia)
01/2018

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
03/2009 - 03/2007
3Hydrogen Sulfide (Sulfide, Hydrogen)IBA
07/2019 - 11/2007
3sodium sulfideIBA
07/2019 - 02/2014
3T-Type Calcium Channels (T-Type Calcium Channel)IBA
01/2019 - 01/2017
3SodiumIBA
03/2017 - 09/2007
3sodium bisulfide (NaHS)IBA
01/2016 - 11/2007
3LigandsIBA
12/2012 - 06/2006
3Pharmaceutical PreparationsIBA
10/2010 - 04/2003
3Dizocilpine Maleate (Dizocilpine)IBA
10/2007 - 06/2007
2EnzymesIBA
12/2022 - 11/2007
2Tuberculin (PPD)IBA
07/2022 - 01/2022
2Proteins (Proteins, Gene)FDA Link
01/2019 - 04/2005
2Arginine (L-Arginine)FDA Link
12/2017 - 07/2015
2Sodium-Glucose Transport ProteinsIBA
03/2017 - 11/2016
2Glucose (Dextrose)FDA LinkGeneric
01/2017 - 10/2010
2Protein Isoforms (Isoforms)IBA
01/2016 - 02/2013
2NNC 55-0396IBA
02/2014 - 02/2013
2Insulin (Novolin)FDA Link
09/2013 - 11/2010
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2013 - 10/2010
2GasotransmittersIBA
02/2013 - 11/2007
2Ethosuximide (Zarontin)FDA LinkGeneric
02/2013 - 11/2007
2Hypoglycemic Agents (Hypoglycemics)IBA
10/2010 - 09/2010
2XenonIBA
01/2010 - 08/2002
220-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
12/2007 - 05/2006
2N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamideIBA
12/2007 - 05/2006
2Neuroprotective AgentsIBA
08/2007 - 06/2007
2Tissue Plasminogen Activator (Alteplase)FDA Link
06/2007 - 05/2006
2PPAR gammaIBA
06/2006 - 03/2003
2SaltsIBA
04/2005 - 11/2004
2SEA 0400IBA
11/2004 - 11/2004
2ozagrelIBA
04/2003 - 08/2002
2ThromboxanesIBA
04/2003 - 08/2002
2TTC 909IBA
04/2003 - 08/2002
2Epoprostenol (Prostacyclin)FDA LinkGeneric
04/2003 - 08/2002
2LipidsIBA
04/2003 - 08/2002
2TEI 9090 (clinprost)IBA
04/2003 - 08/2002
2ValeratesIBA
04/2003 - 08/2002
2Ligases (Synthetase)IBA
04/2003 - 08/2002
29-O-methanoprostaglandin IIBA
04/2003 - 08/2002
1Transaminases (Aminotransferases)IBA
12/2022
1Calcium Channels (Calcium Channel)IBA
07/2019
12- (4- cyclopropylphenyl)- N- (1- (5- ((2,2,2- trifluoroethyl)oxo)pyridin- 2- yl)ethyl)acetamideIBA
07/2019
1Immunoglobulin G (IgG)IBA
06/2019
1Immunoglobulin M (IgM)IBA
06/2019
1Bortezomib (Velcade)FDA Link
01/2019
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2019
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2018
1vexibinolIBA
01/2018
16-prenylnaringeninIBA
01/2018
1S 6 (S-6)IBA
01/2018
1Blood Glucose (Blood Sugar)IBA
03/2017
1PhosphatidylserinesIBA
01/2017
1LipopolysaccharidesIBA
01/2017
1Prothrombin (Factor II)IBA
01/2017
1AsparagineIBA
01/2017

Therapy/Procedure

3Therapeutics
09/2013 - 06/2007
2Oral Administration
11/2020 - 02/2013
2Ligation
01/2018 - 01/2018
2Microspheres (Microsphere)
04/2003 - 08/2002
1Blood Transfusion (Blood Transfusions)
11/2021
1Hysterectomy
11/2021